sec filing
GY
NASDAQ · GYRE
Gyre Therapeutics, Inc.
Healthcare · Biotechnology
$6.76
Up+$0.30 (+4.44%)
Updated Oct 9, 2026, 4:16 PM
SID Score
2.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 715.86M
- P/E ratio
- 56.8
- Dividend yield
- 0.00%
- 52-week range
- $5.44 – $8.51
- Volume
- 82.84K
- Avg. volume
- 76.81K
Price performance · GYRE
GYRE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
GYRE closed at $6.76 after 21 trading sessions, up 0.30% for the selected period.
- Last close
- $6.76
- Period change
- +0.30%
- Period low
- $6.69
- Period high
- $7.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $7.04 | $7.04 | $6.74 | $6.76 | 82.84K |
| Oct 7, 2026 | $7.03 | $7.145 | $6.99 | $7.04 | 99.19K |
| Oct 6, 2026 | $7.42 | $7.42 | $7.01 | $7.08 | 133.97K |
| Oct 5, 2026 | $7.17 | $7.43 | $7.0855 | $7.35 | 181.46K |
| Oct 2, 2026 | $7.09 | $7.35 | $7.08 | $7.11 | 163.75K |
| Oct 1, 2026 | $7.35 | $7.38 | $7.00 | $7.00 | 140K |
| Sep 30, 2026 | $7.32 | $7.38 | $7.13 | $7.33 | 159.79K |
| Sep 29, 2026 | $7.52 | $7.735 | $7.31 | $7.32 | 115.12K |
| Sep 28, 2026 | $7.35 | $7.56 | $7.30 | $7.49 | 137.05K |
| Sep 25, 2026 | $7.39 | $7.42 | $7.13 | $7.35 | 134.84K |
| Sep 24, 2026 | $7.40 | $7.44 | $6.81 | $7.33 | 327.69K |
| Sep 23, 2026 | $7.49 | $7.50 | $7.04 | $7.40 | 164.56K |
| Sep 22, 2026 | $7.40 | $7.61 | $7.26 | $7.49 | 227.13K |
| Sep 21, 2026 | $7.55 | $7.57 | $7.21 | $7.43 | 364.87K |
| Sep 18, 2026 | $7.12 | $7.56 | $7.10 | $7.55 | 1.2M |
| Sep 17, 2026 | $6.80 | $7.20 | $6.80 | $7.18 | 143.91K |
| Sep 16, 2026 | $6.70 | $6.855 | $6.59 | $6.70 | 126.37K |
| Sep 15, 2026 | $6.69 | $6.7163 | $6.46 | $6.69 | 97.77K |
| Sep 14, 2026 | $6.82 | $7.035 | $6.685 | $6.69 | 104.12K |
| Sep 11, 2026 | $6.86 | $6.95 | $6.73 | $6.73 | 69.8K |
| Sep 10, 2026 | $6.93 | $6.96 | $6.74 | $6.74 | 83.1K |
Latest GYRE news
The latest Smart Investors Daily articles mentioning GYRE.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

